Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 233 - Carboxylic acid amides
Patents for C07C 233 - Carboxylic acid amides (28,881)
10/2007
10/24/2007EP1846372A2 Compounds for inflammation and immune-related uses
10/24/2007EP1846365A1 Diamine calcium channel blockers
10/24/2007EP1846362A2 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
10/24/2007EP1846347A1 Method for the use of [11c] carbon monoxide in labeling synthesis of 11c-labelled compounds by thermally induced free radical carbonylation
10/24/2007EP1534671A4 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/24/2007EP1287006B1 Antitumoral compounds
10/24/2007CN100344616C Compounds for the treatment of metabolic disorders
10/24/2007CN100344608C Production of high-purity capsaicin crystal by ion exchange resin method
10/23/2007US7285680 β-alanine derivatives and the use thereof
10/23/2007US7285604 Process for production of molecular devices
10/23/2007US7285600 Nitrile oxide precursor compound for use as irreversible cross-linking agent in polymers
10/18/2007WO2007116781A1 Process for production of acrylamide
10/18/2007WO2007115685A1 Method for producing biphenylamines from vinyl anilines
10/18/2007WO2007115645A1 Method for producing 2-ethynylphenyl acetamides
10/18/2007US20070244199 Anti-mycobacterial formulation
10/18/2007US20070244198 Carboxylic Derivatives
10/18/2007US20070244197 Bactericide against gramnegative bacteria; respiratory system disorders
10/18/2007US20070244172 Compounds for the treatment of metabolic disorders
10/18/2007US20070244171 Compounds for the treatment of metabolic disorders
10/18/2007US20070244153 Diamine Derivative, Process of Preparation Thereof, and Fungicide Comprising Diamine Derivative as an Active Ingredient
10/18/2007US20070244141 Compounds for the treatment of metabolic disorders
10/18/2007US20070244122 Derivatives of sulindac, use thereof and preparation thereof
10/18/2007US20070244116 c-MET MODULATORS AND METHOD OF USE
10/18/2007US20070244007 Cis-Alkoxyspiro-Substituted Tetramic Acid Derivatives
10/18/2007DE69233686T2 Heteoaryl-Piperidine und Piperazine und ihre Anwendung als antipsychotisches und analgetisches Mittel Heteoaryl-piperidines and piperazines and their use as antipsychotic and analgesic agent
10/17/2007EP1844002A1 1-acylamino-2-hydroxy-3-amino-w-arylalkanes as renin inhibitors
10/17/2007EP1844001A1 Metabolites of 2-arylpropionic acid derivatives and pharmaceutical compositions containing them
10/17/2007EP0970195B1 Fatty-acid amide hydrolase
10/17/2007CN101056852A Iodine-phenyl-substituted cyclic cetoenols
10/17/2007CN101056846A Diphenylethylene compounds and uses thereof
10/17/2007CN101056845A Substituted aniline derivatives
10/17/2007CN101053558A Diphenylethylene compounds and uses thereof
10/16/2007US7282608 Inhibitors of histone deacetylase
10/16/2007US7282607 Process for the preparation of iopamidol
10/16/2007US7282605 N-allylcarboxamide derivative undergoes rearrangement reaction diastereoselectively in the presence of a base to give a 2-allylcarboxamide derivative, derivative is subjected to a carbamation reaction and solvolysis to give an optically active 2-allylcarboxylic acid ester, and ester is hydrolyzed
10/16/2007US7282501 Drugs for treatment of Syndrome X, diabetes, hypoglycemic agents, antilipemic agents, arteriosclerosis and cardiovascular agents
10/16/2007US7282363 Container body for the culture of embryos, sized and configured for intravaginal accommodation, a resealable closure permitting selective access to the interior of the container body; collecting and retrieval of embryos
10/11/2007WO2007113644A2 New hdac inhibitors
10/11/2007WO2007113309A2 Compounds which inhibit the glycine transporter and uses thereof
10/11/2007WO2007005740A3 Sunless tanning substrate
10/11/2007US20070238783 Beta-benzyloxyaspartate derivatives with amino group on benzene ring
10/11/2007US20070238780 Multifunctional enhancement systems for personal care, household, and wood products
10/11/2007US20070238671 Isopeptide Gap Junction Modulators
10/11/2007US20070238669 Human glucagon-like-peptide-1 modulators and their use in the treatment of diabetes related conditions
10/11/2007US20070238653 Methamphetamine-like hapten compounds, linkers, carriers and compositions and uses thereof
10/11/2007CA2648121A1 Preparation of chiral amides and amines
10/10/2007EP1841728A1 Compounds for treating urinary incontinence
10/10/2007EP1841727A1 Glycine transport inhibitors
10/10/2007EP1841726A1 An asymmetric synthesis of ( s ) - ( + ) -3- (aminomethyl) -5-methylhexanoic acid
10/10/2007EP0870014B9 Aldolase catalytic antibody
10/10/2007CN101052622A Opiate intermediates and methods of synthesis
10/10/2007CN101050190A Method for producing erucamid erucyl amide through circulating reactor
10/10/2007CN101050189A Process for the synthesis of n-acyl-2-amino-4-alkoxy-5-nitrobenzoic acids
10/10/2007CN101050188A New installation for producing dimethyl formamide, and new technique of using the installation
10/10/2007CN100341853C Taxane with alkyl subtituted lateral chain and medicinal composition containing said compound
10/10/2007CN100341848C Method for the purification of dimethylacetamide (DMAc)
10/09/2007US7279586 Intermediates for the hemisynthesis of taxanes and preparation processes therefor
10/09/2007US7279477 Cardiovascular disease, diabetes, acidosis, cancer, obesity; such as 1-butyl-3,3-dimethyl-1-(4-(2,2,2-trifluoro-1-hydroxy-1-trifluoromethyl -ethyl)-phenyl)-thiourea
10/09/2007US7279470 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
10/09/2007CA2252084C Cytoprotective compounds
10/09/2007CA2204527C 2,2-dichloralkane-carboxylic acids, processes for their production and pharmaceutical agents containing these
10/04/2007WO2007110727A2 Amide stabilized hydroxyethylamines
10/04/2007WO2007110225A1 Improved crystalline material
10/04/2007WO2007075847A3 Glucokinase activators
10/04/2007WO2007062308A3 Homo- and heterocyclic compounds suitable as cetp inhibitors
10/04/2007WO2007060215A3 (r)-arylkylamino derivatives and pharmaceutical compositions containing them
10/04/2007WO2007049158A3 Ppar modulating biaromatic compounds
10/04/2007US20070232829 Low temperature drying of wet crystals; antidiabetic agents; free of H-type polymorphs
10/04/2007US20070232654 Novel Compounds and Compositions as Cathepsin Inhibitors
10/04/2007US20070231892 Isolation of nucleic acids
10/04/2007US20070231393 System and Device for Magnetic Drug Targeting with Magnetic Drug Carrier Particles
10/04/2007DE102006014722A1 Verfahren zum Herstellen von 2-Ethinylphenylacetamiden A process for producing 2-Ethinylphenylacetamiden
10/04/2007CA2642872A1 Improved crystalline material
10/03/2007EP1838664A1 Manufacture process of n-substituted salicylamides
10/03/2007EP1838663A1 Glycine transport inhibitors
10/03/2007EP1838278A1 2-c-substituted propane-1,3-dicarbonyl compounds and their use in neutralising malodour
10/03/2007EP1339664B1 Production of butane tetracarboxylic acid derivatives by means of coupled electrosynthesis
10/03/2007EP1080065B1 A method of permanent fluorescent assay
10/03/2007CN101048367A New tyrosine derivative as ppar gamma regulator
10/03/2007CN101045696A Preparation process of arylformamidoimidazole arylaceton
10/03/2007CN101045695A Hydro-reduction method for preparing quinolone intermediate
10/03/2007CN100340541C Process for preparation of alpha-hydroxycarboxylic acid amides
10/02/2007US7276613 G protein coupled receptor antagonists with higher enzyme resistance than anandamide; amido, (dithio)carbamate, and (thio)urea analogs; antiepileptic agents, analgesics, antiemetics, immunosuppressants, anorexigenic agents; glaucoma
10/02/2007US7276534 Carbon-substituted diketopiperazine delivery systems
10/02/2007US7276518 For therapy of neuropathic or chronic pain
09/2007
09/27/2007WO2007108483A1 N-2-(hetero)arylethylcarboxamide derivative, and pest-controlling agent comprising the same
09/27/2007WO2007107828A2 Amine derivatives
09/27/2007US20070225515 Analgesics, anaesthetics, antifoulants, aversants, irritants, incapacitants and compositions containing the same
09/27/2007US20070225374 Hydroxypropyl Amides for the Treatment of Alzheimer's Disease
09/27/2007US20070225373 Zn2Motif-Tethered Short-Chain Fatty Acids as a Novel Class of Histone Deacetylase
09/27/2007US20070225365 Cetp Inhibitors
09/27/2007US20070225329 Aryl aniline beta2 adrenergic receptor agonists
09/27/2007US20070225288 Indene Derivatives and Process for the Preparation Thereof
09/27/2007US20070225229 N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
09/27/2007US20070225170 2-Halo-6-Alkylphenyl-Substituted Tetramic Acid Derivatives
09/27/2007US20070225167 2-Ethyl-4,6-Dimethyl-Phenyl-Substituted Tetramic Acid Derivatives as Pest Control Agents and/or Herbicides
09/27/2007US20070224263 Aminoalkylphosphonates and related compounds as Edg receptor agonists
09/26/2007EP1836464A2 Thermally-responsive materials and devices comprising such materials
09/26/2007EP1836157A1 Process for the preparation of 1-amino-3,5-dimethyladamantane hydrochloride
09/26/2007EP1380121B1 Process to prepare oxazolidinones
1 ... 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 ... 289